tiprankstipranks
Trending News
More News >
Traws Pharma (TRAW)
NASDAQ:TRAW
US Market

Traws Pharma (TRAW) Financial Statements

Compare
1,857 Followers

Traws Pharma Financial Overview

Traws Pharma's market cap is currently $9.29M. The company's EPS TTM is $2.17; its P/E ratio is ―; Traws Pharma is scheduled to report earnings on May 15, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 226.00K$ 226.00K$ 226.00K$ 226.00K$ 231.00K
Gross Profit$ 214.00K$ 210.00K$ 212.00K$ 212.00K$ 231.00K
Operating Income$ -142.37M$ -20.30M$ -19.63M$ -16.50M$ -24.99M
EBITDA$ -24.90M$ -20.28M$ -19.61M$ -16.48M$ -24.98M
Net Income$ -166.52M$ -18.95M$ -18.96M$ -16.16M$ -25.16M
Balance Sheet
Cash & Short-Term Investments$ 21.34M$ 20.82M$ 38.76M$ 55.07M$ 19.02M
Total Assets$ 24.96M$ 22.68M$ 39.37M$ 55.48M$ 19.99M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -21.34M$ -20.82M$ -38.76M$ -55.07M$ -19.02M
Total Liabilities$ 56.59M$ 12.01M$ 11.06M$ 9.36M$ 13.81M
Stockholders' Equity$ -31.63M$ 10.67M$ 28.31M$ 46.12M$ 6.17M
Cash Flow
Free Cash Flow$ -29.79M$ -17.95M$ -16.29M$ -19.49M$ -23.09M
Operating Cash Flow$ -29.79M$ -17.93M$ -16.29M$ -19.49M$ -23.07M
Investing Cash Flow$ -3.65M$ -14.00K$ 0.00$ 0.00$ -15.00K
Financing Cash Flow$ 33.98M$ 0.00$ 0.00$ 55.56M$ 19.36M
Currency in USD

Traws Pharma Earnings and Revenue History

Traws Pharma Debt to Assets

Traws Pharma Cash Flow

Traws Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis